Article

SARS-CoV-2 Antibody Seroprevalence and Stability in a Tertiary Care Hospital-Setting

2020-10-22

Abstract excerpt

Background: SARS-CoV-2 infectionhas caused 64,469 deaths in India, with 7, 81, 975 active cases till 30th August 2020, lifting it to 3rd rank globally. To estimate the burden of the disease with time it is important to undertake a longitudinal seroprevalence study which will also help to understand the stability of anti SARS-CoV-2 antibodies. Various studies have been conducted worldwide to assess the antibody st...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 4625ed19-2b27-5886-9a21-10ba9b186b69
DOI: 10.2139/ssrn.3696827

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

SARS-CoV-2 Antibody Seroprevalence and Stability in a Tertiary Care Hospital-SettingDOI 10.2139/ssrn.3696827Read

“SARS-CoV-2 antibody seroprevalence and stability in a tertiary care hospital-setting”Semantic proximity Read

Serial SARS-CoV-2 Seropravelence Studies in Delhi July-August 2020: Indications of Pre-existing Cross-reactive Antibodies and Implications for Disease ProgressionSemantic proximity Read

Prevalence of Igg Antibodies Against SARS-CoV-2 Among the General Population and Healthcare Workers in India, June–July 2021Semantic proximity Read

SARS-CoV-2 seroprevalence in Delhi, India - September-October 2021 – a population based seroepidemiological studySemantic proximity Read

Performance Assessment of First-Generation Anti-SARS-CoV-2 Serological AssaysSemantic proximity Read

SARS-CoV-2 Antibody Prevalence in India: Findings from the Second Nationwide Household Serosurvey, August - September 2020Semantic proximity Read

The burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population: Results from a statewide survey in Karnataka, IndiaSemantic proximity Read

Second round statewide survey for estimation of the burden of active infection and anti-SARS-CoV-2 IgG antibodies in the general population of Karnataka, IndiaSemantic proximity Read

Prevalence of IgG Antibodies to SARS-CoV-2 in Wuhan – Implications for the Longevity of Antibodies Against SARS-CoV-2Semantic proximity Read

SARS-CoV-2 Sero-Prevalence Among General Population and Healthcare Workers in India, December 2020 - January 2021Semantic proximity Read

Performance, Dynamic Change and Clinical Relevance of SARS-CoV-2 Antibody ResponsesSemantic proximity Read

SARS-CoV-2 Seroprevalence Studies: A Rapid ReviewSemantic proximity Read